Skip Navigation

Phone Service Update

We apologize that callers may intermittently experience longer than usual wait times. We are working with our phone service provider as they try to improve the situation as soon as possible.

COVID-19 Vaccine Information |Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Find a Doctor

Find a Researcher


Evan Mark Braunstein, M.D., Ph.D.

Photo of Dr. Evan Mark Braunstein, M.D., Ph.D.
  • Assistant Professor of Medicine


Anemias, Hematology, Leukopenia, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders, Thrombocytopenias


The Johns Hopkins Hospital

600 N. Wolfe Street
Blalock Building, Suite 266
Baltimore, MD 21287 map

The Johns Hopkins Hospital

600 N. Wolfe Street
Ross Building, Room 1016A
Baltimore, MD 21287 map
Fax: 410-955-0185


Dr. Evan M. Braunstein is an Assistant Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include inherited hematologic malignancies, myeloproliferative neoplasms myelodysplastic syndromes, clonal hematopoiesis of indeterminate potential, cytopenias and hematology.

Dr. Braunstein earned his M.D. and Ph.D. at Yeshiva University’s Albert Einstein College of Medicine. He completed his residency in internal medicine at Mount Sinai Medical Center in New York. He performed a fellowship in hematology at Johns Hopkins. more


  • Assistant Professor of Medicine
  • Assistant Professor of Oncology

Departments / Divisions



  • MD, Albert Einstein College of Medicine (2009)


  • The Mount Sinai Hospital / Internal Medicine (2011)


  • Johns Hopkins University School of Medicine / Oncology (2015)

Board Certifications

  • American Board of Internal Medicine / Hematology (2016)
  • American Board of Internal Medicine / Internal Medicine (2015)

Research & Publications

Research Summary

Dr. Braunstein's research focuses on inherited predisposition to hematologic diseases. His laboratory studies the inherited genetic changes in DNA that increase susceptibility to disease. Blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes are traditionally thought to be acquired disorders, however there is increasing evidence that inherited genetic changes play a role. In addition, Dr. Braunstein studies blood disorders such as atypical hemolytic uremic syndrome which are caused in part by genetic mutations.  

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button